Rosenberg, J., Sridhar, S. S., Zhang, J., Smith, D., Ruether, D., Flaig, T. W., . . . Petrylak, D. P. (2020). EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma. J Clin Oncol.
Trích dẫn kiểu ChicagoRosenberg, Jonathan, et al. "EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma." J Clin Oncol 2020.
Trích dẫn MLARosenberg, Jonathan, et al. "EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma." J Clin Oncol 2020.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.